|
Vol 52(2018) N 4 p. 570-576; DOI 10.1134/S0026893318040027  Y.I. Ammour1*, O.O. Ryabaya2, A.V. Milovanova1, A.V. Sidorov1, I.E. Shohin4, V.V. Zverev1 , T.V. Nasedkina3 Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines 1Mechnikov Institute of Vaccines and Sera, Moscow, 105064 Russia2Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478 Russia 3Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia 4OOO Center of Pharmaceutical Analytics, Moscow, 117246 Russia *yulia.ammour@yahoo.fr Received - 2017-11-20; Accepted - 2017-12-12 The oncolytic potential of the attenuated mumps virus (MV) vaccine strain Leningrad-3 (L-3) was evaluated in a panel of four human metastatic melanoma cell lines. The lines were shown to be susceptible and permissive to MV infection. Efficient MV replication led to death of melanoma cells, but the effect differed among the cell lines. Possible mechanisms mediating the selectivity of MV L-3 towards the cell lines were explored. Replicative and oncolytic activity of MV was found to depend on the expression pattern of type I interferon genes. None of the melanoma cell lines showed induction of expression of the total spectrum of genes required to inhibit virus replication. Based on the results, MV L-3 was assumed to be a promising oncolytic agent for human melanoma cells. oncolytic viruses, mumps virus, metastatic melanoma |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
